Chronic exposure to excess iron promotes EMT and cancer via p53 loss in pancreatic cancer
Based on the evidence that hemochromatosis, an iron-overload disease, drives hepatocellular carcinoma, we hypothesized that chronic exposure to excess iron, either due to genetic or environmental causes, predisposes an individual to cancer. Using pancreatic cancer as our primary focus, we employed c...
Saved in:
Main Authors: | Yangzom D. Bhutia (Author), Jiro Ogura (Author), Paul J. Grippo (Author), Carolina Torres (Author), Toshihiro Sato (Author), Mitchell Wachtel (Author), Sabarish Ramachandran (Author), Ellappan Babu (Author), Sathish Sivaprakasam (Author), Devaraja Rajasekaran (Author), Bradley Schniers (Author), Nhu On (Author), Logan Smoot (Author), Muthusamy Thangaraju (Author), Jaya P. Gnana-Prakasam (Author), Vadivel Ganapathy (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The amino acid transporter SLC6A14 in cancer and its potential use in chemotherapy
by: Yangzom D. Bhutia, et al.
Published: (2014) -
SLC6A14 and SLC38A5 Drive the Glutaminolysis and Serine-Glycine-One-Carbon Pathways in Cancer
by: Tyler Sniegowski, et al.
Published: (2021) -
Induction of Oxidative Stress and Ferroptosis in Triple-Negative Breast Cancer Cells by Niclosamide via Blockade of the Function and Expression of SLC38A5 and SLC7A11
by: Marilyn Mathew, et al.
Published: (2024) -
Pharmacologic inducers of the uric acid exporter ABCG2 as potential drugs for treatment of gouty arthritis
by: Bojana Ristic, et al.
Published: (2020) -
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
by: Longfa Kou, et al.
Published: (2018)